A CASE REPORT OF SEPSIS ASSOCIATED WITH ESCHERICHIA COLI 0157:H7
DOI:
https://doi.org/10.58395/7gqkar88Keywords:
E. coli O157:H7, hemolytic uremic syndrome, Verotoxin-producing Escherichia coli,, antibioticsAbstract
The reports of infections and outbreaks due to Escherichia coli 0157:H7 have increased in the EU for the last five years. The clinical spectrum of the infection varies from hemorrhagic colitis, hemolytic-uremic syndrome (HUS) and rarely, thrombotic thrombocytopenic purpura. This infection is new to Bulgaria, and we report a case of VT1 and VT2 positive E. coli O157:H7 with the presentation of this organism with the onset of haemorrhagic colitis, HUS and lethal exitus of the patient.
Downloads
References
Ameer MA, Wasey A, Salen P. Escherichia coli (e Coli 0157 H7) [Updated 2023 Aug 8]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2023 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK507845/
Glenn Buvens, et. al. Verocytotoxin-Producing Escherichia coli Incidence and Virulence Determinants of Infections in the Brussels-Capital Region, Belgium, in 2008-2010. J. Clin. Microbiol. 2012, 50(4):1336. https://doi.org/10.1128/JCM.05317-11.
Piérard D. Infections with verotoxin-producing Escherichia coli. Acta Clin Belg. 1992;47(6):387-96. https://doi.org/10.1080/17843286.1992.11718260 PMID: 1337811.
Larry M. Bush , Maria T. Vazquez-Pertejo. Infection by Escherichia coli O157:H7 and Other Enterohemorrhagic E. coli (EHEC). 2022. https://www.msdmanuals.com/professional/infectious-diseases/gram-negative-bacilli/infection-by-escherichia-coli-o157-h7-and-other-enterohemorrhagic-e-coli-ehec
Griffin PM, Ostroff SM, Tauxe RV, Greene KD, Wells JG, Lewis JH, Blake PA. Illnesses associated with Escherichia coli O157:H7 infections. A broad clinical spectrum. Ann Intern Med. 1988 Nov 1;109(9):705-12. https://doi.org/10.7326/0003-4819-109-9-705 PMID: 3056169.
Andersen H. "Children on the frontline against E. coli": typical hemolytic-uremic syndrome. Clin Lab Sci. 2005 Spring;18(2):90-9.
Tarr, P. I. (1995). Escherichia coli 0157:H7: Clinical, Diagnostic, and Epidemiological Aspects of Human Infection. 20(1), 1-10. https://doi.org/10.1093/clinids/20.1.1
Moxley RA. Escherichia coli 0157:H7: an update on intestinal colonization and virulence mechanisms. Anim Health Res Rev. 2004 Jun;5(1):15-33. https://doi.org/10.1079/AHR200463
Nitschke M, Sayk F, Hartel C, Roseland RT, Hauswaldt S, Steinhoff J, Fellermann K, Derad I, Wellhoner P, Buning J, Tiemer B, Katalinic A, Rupp J, Lehnert H, Solbach W, Knobloch JK, 2012. Association between azithromycin therapy and duration of bacterial shedding among patients with Shiga toxin-producing enteroaggregative Escherichia coli O104:H4. JAMA 307, 1046-1052. https://doi.org/10.1001/jama.2012.264
Wong CS, Mooney JC, Brandt JR, Staples AO, Jelacic S, Boster DR, Watkins SL, Tarr PI, 2012. Risk factors for the hemolytic uremic syndrome in children infected with Escherichia coli O157:H7: a multivariable analysis. Clin. Infect. Dis 55, 33-41 https://doi.org/10.1093/cid/cis299
Downloads
Published
Issue
Section
License
Copyright (c) 2024 Asst. Prof. Maria Pavlova, PhD , Rositsa Stoyanova, Metodi Popov, Valeri Velev (Author)
This work is licensed under a Creative Commons Attribution 4.0 International License.
